Actively Recruiting
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Led by Inova Health Care Services · Updated on 2026-03-16
3000
Participants Needed
1
Research Sites
4278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates. To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017. To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella). • Assess survival at three time points.
CONDITIONS
Official Title
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock.
- Adults aged 18 to 85 years treated at the Inova Heart and Vascular Institute.
You will not qualify if you...
- Patients under the age of 18 will be excluded.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Inova Fairfax Hospital
Falls Church, Virginia, United States, 22042
Actively Recruiting
Research Team
B
Bhruga Shah
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here